Study on Simvastatin for Preventing Recurrent Pancreatitis in Patients

Study on Simvastatin for Preventing Recurrent Pancreatitis in Patients
Study on Simvastatin for Preventing Recurrent Pancreatitis in Patients

Simvastatin is a medication used in this trial to see if it can help prevent new episodes of recurrent pancreatitis . It is commonly used to lower cholesterol and reduce the risk of heart disease, but in this study , researchers are investigating whether it can also reduce the frequency of pancreatitis attacks.

Clinical design examples clinical research study examples ICDK
Clinical design examples clinical research study examples ICDK

In conclusion, the SIMBA study is a researcher-driven triple-blind randomized placebo-controlled, parallel-group, multicenter trial aiming to compare recurrence of new episodes of pancreatitis in patients with recurrent AP or acute flares of CP, consuming simvastatin vs. placebo.

Study Details

Clinical Trial Designs
Clinical Trial Designs

The main aim of SIMBA ( SIMvastatin in the prevention of recurrent pancreatitis , a triple Blind rAndomized controlled multicenter trial) is to compare the recurrence rate of pancreatitis in patients with established recurrent pancreatitis (acute pancreatitis and acute flares in chronic pancreatitis ) consuming simvastatin versus placebo.

Methods: The SIMBA study is a triple-blind randomized placebo-controlled, parallel-group multicenter trial. Patients with recurrent AP or with acute flares of CP (at least two episodes in the last 12 months) will be randomized to receive simvastatin 40 mg daily or placebo.

PDF A Multicenter International Cohort Analysis of 1435 Cases to Support Clinical Trial
PDF A Multicenter International Cohort Analysis of 1435 Cases to Support Clinical Trial

Simvastatin in the Prevention of Recurrent Pancreatitis

In conclusion, the SIMBA study is a researcher-driven triple-blind randomized placebo-controlled, parallel-group, multicenter trial aiming to compare recurrence of new episodes of pancreatitis in patients with recurrent AP or acute flares of CP, consuming simvastatin vs. placebo.

Conclusion This trial, evaluating simvastatin versus placebo for the prevention of pancreatitis , did not demonstrate a reduction in recurrence rate, although results might be underpowered due to early termination. The relationship between statins in these patients and new-onset diabetes requires further investigation.

Clinical trial design in oncology The Lancet Oncology
Clinical trial design in oncology The Lancet Oncology

Simvastatin in the prevention of recurrent pancreatitis

Simvastatin in the prevention of recurrent pancreatitis : a triple-blinded randomised clinical trial (the SIMBA trial)

262 SIMVASTATIN IN THE PREVENTION OF RECURRENT PANCREATITIS : A TRIPLE-BLINDED RANDOMIZED CLINICAL TRIAL (THE SIMBA TRIAL)

Flow chart describing the clinical trial study design
Flow chart describing the clinical trial study design

Simvastatin in the Prevention of Recurrent Pancreatitis (SIMBA

Recurrent acute pancreatitis and recurrent relapses of inflammation in chronic pancreatitis are an important problem. In some cases, prevention of these acute flares of inflammation is not possible. Population-based studies and meta-analysis of randomized controlled trials suggest that statins may decrease the incidence of acute pancreatitis .

Clinical trial design
Clinical trial design
Pancreatitis acute Diagnostics Overview of Information and Clinical Research
Pancreatitis acute Diagnostics Overview of Information and Clinical Research
Espen Guideline Clinical Nutrition Pancreatitis 1707936235 PDF
Espen Guideline Clinical Nutrition Pancreatitis 1707936235 PDF
Study Designs in Clinical Trials An Overview PPTX Pharmaceutical Drugs
Study Designs in Clinical Trials An Overview PPTX Pharmaceutical Drugs
Step Up versus Open Approach in the Treatment of Acute Necrotizing Pancreatitis A Case Matched
Step Up versus Open Approach in the Treatment of Acute Necrotizing Pancreatitis A Case Matched
Clinical Trials Study Design Endpoints and Biomarkers Drug Safety and FDA and ICH Guidelines
Clinical Trials Study Design Endpoints and Biomarkers Drug Safety and FDA and ICH Guidelines
Study Design and Strength of Evidence Clinical Trials pptx
Study Design and Strength of Evidence Clinical Trials pptx
POSTERS Trials at Home
POSTERS Trials at Home

About Recurrent acute pancreatitis and recurrent relapses of inflammation in chronic pancreatitis are an important problem. In some cases, prevention of these acute flares of inflammation is not possible. Population-based studies and meta-analysis of randomized controlled trials suggest that statins may decrease the incidence of acute pancreatitis . SIMBA aims to investigate the effect of ...